相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience
Shyam K. Poudel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study
Noémie Kraaijpoel et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure
Christopher J. Pannucci et al.
ANNALS OF THORACIC SURGERY (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
Rocio Figueroa et al.
PLOS ONE (2018)
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial
Arzu Kalayci et al.
THROMBOSIS AND HAEMOSTASIS (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
Holger J. Schunemann et al.
BLOOD ADVANCES (2018)
Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study
J. -P. Galanaud et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool
Rushad Patell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia
H. Sibai et al.
CURRENT ONCOLOGY (2016)
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients
T. van der Hulle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
Uwe Pelzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
Marc Carrier et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Practices to prevent venous thromboembolism: a brief review
Brandyn D. Lau et al.
BMJ QUALITY & SAFETY (2014)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A. Maraveyas et al.
EUROPEAN JOURNAL OF CANCER (2012)
Risk of Recurrent Venous Thromboembolism and Mortality in Patients With Cancer Incidentally Diagnosed With Pulmonary Embolism: A Comparison With Symptomatic Patients
Paul L. den Exter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
S. Barbar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Temporal Trends in Rates of Patient Harm Resulting from Medical Care.
Christopher P. Landrigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations
M. Mandala et al.
ANNALS OF ONCOLOGY (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
PT Vaitkus et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz et al.
CIRCULATION (2004)
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study
R Alikhan et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
分享论文
